ACTIVATION OF ALTERNATIVE RECEPTOR TYROSINE KINASE IN GLIOBLASTOMA MEDIATES RESISTANCE TO PDGFR INHIBITION

被引：0
|
作者：
Ran, C. [1 ]
Liu, H. [1 ]
Zhang, Z. [1 ]
Israel, M. A. [1 ]
Hitoshi, Y. [2 ]
机构：
[1] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH USA
[2] Rosai Hosp, Dept Neurosurg, Yatsushiro, Kumamoto, Japan
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2014年 / 62卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：713 / 713
页数：1
相关论文
共 50 条
  • [1] Mechanisms of resistance to PDGFR inhibition in glioblastoma
    Pastorino, Sandra
    Langley, Emma J.
    Chao, Ying
    Jiang, Pengfei
    Mukthavaram, Rajesh
    Pingle, Sandeep C.
    Kim, Phillip Sangwook
    Singh, Sharat
    Kesari, Santosh
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [2] Original Fucosyltransferase 8 modulates receptor tyrosine kinase activation and temozolomide resistance in glioblastoma cells
    Wei, Kuo-Chen
    Lin, You-Cheng
    Chen, Chia-Hua
    Chu, Yin-Hung
    Huang, Chiung-Yin
    Liao, Wen-Chieh
    Liu, Chiung-Hui
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11): : 5472 - +
  • [3] Activation of alternative HER receptors mediates resistance to EGFR tyrosine kinase inhibitors in breast cancer cells
    Kong, A.
    Calleja, V.
    Leboucher, P.
    Harris, A.
    Parker, P.
    Larijani, B.
    EJC SUPPLEMENTS, 2008, 6 (09): : 9 - 9
  • [4] Activation of alternative HER receptors mediates resistance to EGFR tyrosine kinase inhibitors in breast cancer cells
    Kong, A.
    Calleja, V.
    Leboucher, P.
    Harris, A.
    Parker, P.
    Larijani, B.
    EJC SUPPLEMENTS, 2008, 6 (12): : 155 - 155
  • [5] Alternative splicing dictates receptor tyrosine kinase fates in glioblastoma.
    Nair, Sindhu
    Rajbhandari, Rajani
    Hurt, Centdrika
    Bredel, Markus
    CANCER RESEARCH, 2021, 81 (13)
  • [6] INHIBITION OF MER RECEPTOR TYROSINE KINASE IMPEDES MIGRATION OF GLIOBLASTOMA MULTIFORME
    Keating, Amy
    Jones, Ashley
    Graham, Doug
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 897 - 897
  • [7] Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
    Sadahiro, Hirokazu
    Kang, Kyung-Don
    Gibson, Justin T.
    Minata, Mutsuko
    Yu, Hai
    Shi, Junfeng
    Chhipa, Rishi
    Chen, Zhihong
    Lu, Songjian
    Simoni, Yannick
    Furuta, Takuya
    Sabit, Hemragul
    Zhang, Suojun
    Bastola, Soniya
    Yamaguchi, Shinobu
    Alsheikh, Hebaallah
    Komarova, Svetlana
    Wang, Jun
    Kim, Sung-Hak
    Hambardzumyan, Dolores
    Lu, Xinghua
    Newell, Evan W.
    DasGupta, Biplab
    Nakada, Mitsutoshi
    Lee, L. James
    Nabors, Burt
    Norian, Lyse A.
    Nakano, Ichiro
    CANCER RESEARCH, 2018, 78 (11) : 3002 - 3013
  • [8] Receptor tyrosine kinase signaling mediates resistance in NRAS mutant melanoma
    Robinson, James
    Rebecca, Vito
    Chen, Guo
    Davies, Michael
    VanBrocklin, Matthew
    Holmen, Sheri
    CANCER RESEARCH, 2015, 75
  • [9] ALTERNATIVE RECEPTOR TYROSINE KINASE SIGNALING AS A RESISTANCE MECHANISM TO ERK INHIBITION IN HIGH-GRADE GLIOMAS
    Stanton, Ann-Catherine
    Koncar, Robert
    Golbourn, Brian
    Wassell, Michelle
    Agrawal, Nishant
    Dey, Brittany
    Myers, Max
    Mack, Stephen
    Pollack, Ian
    Agnihotri, Sameer
    NEURO-ONCOLOGY, 2019, 21 : 50 - 51
  • [10] Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ
    O'Sullivan, Susannah
    Tay, Mei Lin
    Lin, Jian-Ming
    Bava, Usha
    Callon, Karen
    Cornish, Jillian
    Naot, Dorit
    Grey, Andrew
    PLOS ONE, 2016, 11 (10):
12345